![Peter B. Heifetz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter B. Heifetz
Amministratore Delegato presso OrPro Therapeutics, Inc.
Profilo
Peter B.
Heifetz is currently the President, Chief Executive Officer & Director at OrPro Therapeutics, Inc. and the Chief Scientific Officer at Rincon Pharmaceuticals, Inc. He holds graduate and doctorate degrees from Duke University.
Posizioni attive di Peter B. Heifetz
Società | Posizione | Inizio |
---|---|---|
Rincon Pharmaceuticals, Inc.
![]() Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | - |
OrPro Therapeutics, Inc.
![]() OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrPro Therapeutics, Inc. develops therapeutic platform based on thioredoxin, a human protein disulfide-reducing enzyme with unique mucus-normalizing, anti-inflammatory and anti-infective properties. The company is headquartered in San Diego, CA. | Amministratore Delegato | - |
Formazione di Peter B. Heifetz
Duke University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Rincon Pharmaceuticals, Inc.
![]() Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Health Technology |
OrPro Therapeutics, Inc.
![]() OrPro Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrPro Therapeutics, Inc. develops therapeutic platform based on thioredoxin, a human protein disulfide-reducing enzyme with unique mucus-normalizing, anti-inflammatory and anti-infective properties. The company is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Peter B. Heifetz